CATX

Perspective Therapeutics, Inc.

12.03 USD
+0.07 (+0.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Perspective Therapeutics, Inc. stock is up 0.84% since 30 days ago. The next earnings date is Aug 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 40 July’s closed higher than June. 100% of analysts rate it a buy.

About Perspective Therapeutics, Inc.

Isoray, Inc. develops, manufactures, and sells isotope-based medical products and devices. CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities.

  • Cantor Fitzgerald
    Tue Jun 25, 10:53
    buy
    confirm
  • Cantor Fitzgerald
    Thu Jun 20, 13:28
    buy
    confirm
  • Oppenheimer
    Tue Jun 18, 10:40
    buy
    confirm
  • Cantor Fitzgerald
    Tue Jun 18, 09:59
    buy
    confirm